VERV · Categories · Form 4

VERV - SEC Form 4 insider transactions

Verve Therapeutics Inc. (VERV) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for VERV

• 317d
  SEC Form 4 filed by Director Maclean Michael F

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  SEC Form 4 filed by Director Yeshwant Krishna

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  Chief Administrative Officer Nickerson Joan closing all direct ownership in the company (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  Chief Executive Officer Kathiresan Sekar closing all direct ownership in the company (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  Chief Scientific Officer Lister Troy closing all direct ownership in the company (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  Chief Financial Officer Dorval Allison closing all direct ownership in the company (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  SEC Form 4 filed by Director Adelman Burt A

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  SEC Form 4 filed by Director Morrison Jodie Pope

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  Officer Ashe Andrew D. closing all direct ownership in the company (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  Chief Technical Ops. Off. Politi Jason closing all direct ownership in the company (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  SEC Form 4 filed by Director Coats Lonnel

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  SEC Form 4 filed by Director Cumbo Alexander

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  SEC Form 4 filed by Director Mikhail Sheila

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 317d
  SEC Form 4 filed by Director Tatsis Ourania

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Coats Lonnel

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Cumbo Alexander

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Morrison Jodie Pope

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Mikhail Sheila

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Adelman Burt A

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Maclean Michael F

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Tatsis Ourania

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 369d
  SEC Form 4 filed by Director Yeshwant Krishna

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 433d
  Chief Administrative Officer Nickerson Joan converted options into 9,315 shares and sold $11,525 worth of shares (2,777 units at $4.15), increasing direct ownership by 60% to 17,420 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 433d
  Officer Ashe Andrew D. converted options into 9,000 shares and sold $11,126 worth of shares (2,681 units at $4.15), increasing direct ownership by 2% to 348,828 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 433d
  Chief Executive Officer Kathiresan Sekar converted options into 33,000 shares and sold $40,761 worth of shares (9,822 units at $4.15), increasing direct ownership by 7% to 346,686 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 433d
  Chief Technical Ops. Off. Politi Jason converted options into 8,815 shares and sold $13,425 worth of shares (3,235 units at $4.15), increasing direct ownership by 65% to 14,226 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 433d
  Chief Scientific Officer Lister Troy converted options into 7,340 shares and sold $9,084 worth of shares (2,189 units at $4.15), increasing direct ownership by 286% to 6,952 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 433d
  Chief Financial Officer Dorval Allison converted options into 11,250 shares and sold $13,903 worth of shares (3,350 units at $4.15), increasing direct ownership by 147% to 13,280 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 517d
  SEC Form 4 filed by Chief Scientific Officer Lister Troy

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 517d
  SEC Form 4 filed by Chief Executive Officer Kathiresan Sekar

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 517d
  SEC Form 4 filed by Chief Financial Officer Dorval Allison

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 517d
  SEC Form 4 filed by Chief Technical Ops. Off. Politi Jason

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 517d
  SEC Form 4 filed by Chief Administrative Officer Nickerson Joan

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 517d
  SEC Form 4 filed by Officer Ashe Andrew D.

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 553d
  Chief Executive Officer Kathiresan Sekar gifted 30,000 shares and received a gift of 30,000 shares, decreasing direct ownership by 8% to 323,508 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 554d
  Chief Financial Officer Dorval Allison converted options into 1,875 shares and sold $3,130 worth of shares (555 units at $5.64), increasing direct ownership by 33% to 5,380 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 709d
  Chief Executive Officer Kathiresan Sekar exercised 30,000 shares at a strike of $2.87, increasing direct ownership by 9% to 351,128 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Adelman Burt A

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Cumbo Alexander

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Yeshwant Krishna

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Mikhail Sheila

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Morrison Jodie Pope

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Coats Lonnel

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Tatsis Ourania

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 713d
  SEC Form 4 filed by Director Maclean Michael F

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 715d
  SEC Form 4 filed by Chief Scientific Officer Lister Troy

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 798d
  Nickerson Joan sold $12,475 worth of shares (1,514 units at $8.24) and converted options into 3,315 shares, increasing direct ownership by 26% to 8,659 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 845d
  SEC Form 4 filed by Ashe Andrew D.

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 845d
  SEC Form 4 filed by Kathiresan Sekar

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 845d
  SEC Form 4 filed by Nickerson Joan

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 845d
  SEC Form 4 filed by Fiedorek Fred T.

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 845d
  SEC Form 4 filed by Bellinger Andrew

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 845d
  SEC Form 4 filed by Dorval Allison

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 922d
  Dorval Allison converted options into 1,875 shares and sold $6,343 worth of shares (554 units at $11.45), increasing direct ownership by 48% to 4,060 units (SEC Form 4)

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 995d
  SEC Form 4 filed by Fiedorek Fred T.

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 1086d
  SEC Form 4 filed by Cumbo Alexander

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 1086d
  SEC Form 4 filed by Adelman Burt A

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 1086d
  SEC Form 4 filed by Yeshwant Krishna

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 1086d
  SEC Form 4 filed by Coats Lonnel

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)
• 1086d
  SEC Form 4 filed by Maclean Michael F

  4 - Verve Therapeutics, Inc. (0001840574) (Issuer)

Other VERV categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends